Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
about
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarinThe endocannabinoid system as an emerging target of pharmacotherapyEndocannabinoid signalling in the blood of patients with schizophreniaThe human eye expresses high levels of CB1 cannabinoid receptor mRNA and proteinPresence and regulation of the endocannabinoid system in human dendritic cellsCharacterisation of the vasorelaxant properties of the novel endocannabinoid N-arachidonoyl-dopamine (NADA)Presynaptic cannabinoid CB(1) receptors are involved in the inhibition of the neurogenic vasopressor response during septic shock in pithed ratsHU-308: a specific agonist for CB(2), a peripheral cannabinoid receptorAnandamide induces cardiovascular and respiratory reflexes via vasosensory nerves in the anaesthetized ratVanilloid receptors on sensory nerves mediate the vasodilator action of anandamideCB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.Neural mechanisms in the cardiovascular responses to acute central hypovolaemia.CB2 cannabinoid receptors contribute to bacterial invasion and mortality in polymicrobial sepsis.Cardiorespiratory anomalies in mice lacking CB1 cannabinoid receptors.Structural determinants for recognition and translocation by the anandamide transporter.Comparative biology of the endocannabinoid system possible role in the immune response.The endocannabinoid system as a target for the treatment of neurodegenerative disease.Functional disassociation of the central and peripheral fatty acid amide signaling systems.The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies.Endocannabinoids and neuroprotection.The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation.Reduced endothelium-dependent relaxation to anandamide in mesenteric arteries from young obese Zucker rats.CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways.Endocannabinoids in liver disease.Endocannabinoid signaling in midbrain dopamine neurons: more than physiology?Cannabinoids and neuroinflammation.The complexities of the cardiovascular actions of cannabinoidsVascular effects of anandamide and N-acylvanillylamines in the human forearm and skin microcirculation.Endocannabinoid system in cardiovascular disorders - new pharmacotherapeutic opportunities.Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling.Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua.The endocannabinoid system: physiology and pharmacology.Cannabinoids as therapeutic agents in cardiovascular disease: a tale of passions and illusionsBlood pressure regulation by endocannabinoids and their receptorsAcute stress increases circulating anandamide and other N-acylethanolamines in healthy humans.Endocannabinoids and liver disease--review.The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids.Endocannabinoids and the haematological system.The peripheral cannabinoid receptor knockout mice: an update.
P2860
Q24643876-9560237C-98B7-43A6-B2BE-F4EFA05EBD2AQ24648473-BBD4D2AE-BB60-4676-9913-CC04B5100DC2Q24800061-03A043F9-9BDC-4DCD-A7AF-57973933D80AQ28141647-DE129A05-C9BF-46AD-9FA8-C92ED78221FAQ28216698-C24DFB68-49E4-4514-AD9E-39D431EAA1F1Q28242911-5FA7BFF7-64F0-489F-8EA1-F978CE1DC3F8Q28263081-5ABFF5E5-6DE1-41B1-9262-E7CE6F18158AQ28343769-6D286480-9F01-4B4E-881C-96B46228AD74Q28361093-F9A8B2B6-3538-45DA-9C64-00BEBCE1FDFFQ28370516-C62F614B-8A98-4514-BF7C-E894460FE891Q30918735-1BA23D99-1B41-4548-806B-792FBB9ED732Q33146518-CBD38988-FCC1-46E0-AEE5-63DC5788F1B4Q33488512-188967B5-44D6-4BFD-BE39-698B1DF9C5A1Q33784193-C16DAACA-4B7B-4050-B0C7-66AD0D66B266Q33861497-34917C73-034B-4768-8056-A0272926DB06Q33994487-EC219232-9458-4633-AA58-2BA73D14ABDEQ34098196-0CD8802C-79E4-4444-9DA4-2D5E95C201FEQ34332678-294D4C15-8B39-4A04-B535-C4FDF6582F09Q34513181-DE7935A6-4971-492E-A616-6C497E7567CEQ34611968-AC5FC412-2DB9-4F6E-AAAA-C3BB43520386Q34626755-C8AD3B47-6309-41C9-B747-5FA6B586AF60Q34698703-A64137FF-E0E6-48C7-ADBD-87CB00707281Q34718182-3E9DBE4A-3886-46D3-8D80-91355807E851Q34733645-2783A5AD-3602-42A9-B4D0-53C3914FBD4EQ34776919-251B9060-4B59-4982-AAA7-1B48DA6B7FEBQ34967151-A4B8F06D-282A-4293-B655-B48AE8075F33Q35046205-C90D07D9-1D41-400A-AC97-E870045AA0C7Q35047093-4DD747DF-4FB1-4363-8AD3-BB770C1B5AFBQ35049157-D4CF02F4-8A39-4D28-B782-7A5C816564A5Q35228889-4788E928-AD94-4E76-B9A7-9B7F25F2F5F5Q35684044-3F8AB33E-60EF-4E7C-86B3-579BBF26D649Q35913259-210493A4-546E-4820-9301-A995E9CD0AB8Q35954057-A6A92E86-70CD-4AEB-AC22-8391BCD382B3Q36052772-2D348DA7-BE4C-403A-98AD-9A8322BED9E2Q36135785-C3975AFD-49EA-4931-A8B4-4077F818FEE4Q36234238-8E606511-13FD-412F-BED6-C1558AB3A7A3Q36257249-FB5AC689-FAC3-4210-B770-74A5918988EDQ36341688-9F9903DB-1372-44AE-9609-5544911F661DQ36358723-B9B7A844-D09B-4A6D-9BB9-B3D4BBF16DF6Q36416347-720D171E-84A3-48AD-AB02-000CFDB83D8E
P2860
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@en
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@nl
type
label
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@en
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@nl
prefLabel
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@en
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@nl
P2093
P921
P356
P1433
P1476
Activation of peripheral CB1 cannabinoid receptors in haemorrhagic shock.
@en
P2093
P2888
P304
P356
10.1038/37371
P407
P577
1997-12-01T00:00:00Z
P5875
P6179
1039786192